MAOB and schizophrenia: In this study, we investigated the in vivo imaging of reactive astrocytes and their association with positive symptoms in patients with schizophrenia using validated MAO-B–binding fluorine 18 ([18F])–labeled THK5351 PET24,25,26 to obtain a more comprehensive understanding of the role of reactive astrocytes in schizophrenia pathophysiology.